Skip to main content
. Author manuscript; available in PMC: 2008 Apr 9.
Published in final edited form as: Bipolar Disord. 2005 Dec;7(6):570–576. doi: 10.1111/j.1399-5618.2005.00264.x

Table 2.

Clinical characteristics of the patient group

Patient no. Sex Age at first scan (years) Age at second scan (years) Interval between scans (years) Rapid cycling Medications at scan 1 Medications at scan 2 Comorbid diagnoses
1 Female 11.7 14.3 2.6 Scans 1 & 2 None None Social phobia
2 Female 15.8 18.6 2.8 Scan 2 None Birth control pills None
3 Female 16.6 18.8 2.2 Scans 1 & 2 None Birth control pills None
4 Female 17.2 20.2 3.0 Scan 2 Carbamazepine, levothyroxine None Oppositional defiant disorder, post-traumatic stress disorder, hypothyroidism
5 Female 21.5 23.6 2.1 Scan 1 None None History of alcohol dependence, hallucinogen and marijuana abuse
6 Male 10.7 12.7 2.0 Scans 1 & 2 Lithium None Oppositional defiant disorder
7 Male 11.7 14.0 2.2 Scan 2 VPA, olanzapine, methylphenidate, clonidine Olanzapine, methylphenidate ADHD, developmental coordination disorder
8 Male 12.0 14.6 2.5 Scan 1 VPA, nortriptyline VPA, nortriptyline, methylphenidate Learning disorder NOS
9 Male 12.2 15.6 3.3 None Lithium, risperidone, sertraline Lithium, VPA, risperidone, sertraline, atomoxetine Learning disorder NOS
10 Male 20.8 23.0 2.2 Scans 1 & 2 None None None

VPA = valproic acid; ADHD = Attention-deficit hyperactivity disorder; NOS = not otherwise specified.